Peregrine to Present at JMP Securities Healthcare Conference September 27, 2011 at 12:00 PM EDT
(firmenpresse) - TUSTIN, CA -- (Marketwire) -- 09/20/11 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced it will present at the 2011 JMP Securities Healthcare Conference in New York, NY on Tuesday, September 27, 2011 at 12:00 PM EDT.
Peregrine's presentation will be webcast live and available for replay until October 27, 2011 at:
For more information about this conference, please visit:
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at .
Contact:
Amy Figueroa or Jay Carlson
Peregrine Pharmaceuticals
(800) 987-8256
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.09.2011 - 12:00 Uhr
Sprache: Deutsch
News-ID 67524
Anzahl Zeichen: 2620
contact information:
Town:
TUSTIN, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 198 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Peregrine to Present at JMP Securities Healthcare Conference September 27, 2011 at 12:00 PM EDT"
steht unter der journalistisch-redaktionellen Verantwortung von
Peregrine Pharmaceuticals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
